Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benfotiamine for Microvascular Complications in Type 1 Diabetes
NCT00117026Phase 2Completed
- Sponsor
- Aker Hospital
- Start
- Aug 2005
- Primary completion
- Jun 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 1 diabetes mellitus (T1D) comparing Benfotiamine with Placebo (2 arms). Primary endpoint: Lower-limb nerve conduction velocity at 24 months. Started Aug 2005; status: completed.
02
Drugs
benfotiamine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00117026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00117026.